Newsletter | September 23, 2026

09.23.26 -- Europe's ATMP Opportunity Still Requires Local Navigation

SPONSOR

 

 

Meet Coriolis Pharma at CPHI Worldwide in Milan to discuss in silico services, formulation development, GMP stability studies, release testing, and product characterization. Click here to learn more

FOCUS ON REGULATORY & COMPLIANCE

Europe's ATMP Opportunity Still Requires Local Navigation

European nations offer a welcoming environment for clinical-phase cell and gene therapies. Don't assume the same flexibility carries through to commercialization.

 

 

Enhance Lentiviral Vector Characterization Using Digital PCR

Digital PCR offers a precise, scalable approach to lentiviral vector characterization, enabling reliable genome titer, vector copy number, and RCL detection while reducing variability.

 

Clearing Residual Reagent Compliance Risks In AAV Manufacturing

Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Explore how specialized assays and strategic partnerships streamline compliance.

 

Scaling MSC Therapies To GMP: The Variability Challenge

Scaling stem cell therapies hinges on managing biological variability. Learn how automated 3D processing, defined media, and robust analytics drive predictable development.

 

Aseptic Filling Technologies That Meet Annex 1 And Ensure GMP Compliance

Strict regulatory shifts demand total process reliability. See how advanced aseptic bag filling tech maintains compliance without compromising yield.

 

Why Cybersecurity Looks Different In Life Sciences

OT cybersecurity can lag in many industries, but life sciences teams take a proactive approach. Their focus on confidentiality and integrity reshapes how risk and protection are prioritized across operations.

 

Bioprocessing Equipment Choices That Directly Accelerate Drug Velocity

As drug modalities grow more complex, speed depends on smarter decisions. Distinguish how bioprocessing equipment choices play a larger role in enabling momentum faster than many teams expect.

 

Myths That Make Early CDMO Engagement Look Like A Risk

Early CDMO engagement isn’t premature—it prevents CMC-driven delays, reduces comparability risk, and aligns AAV manufacturing decisions with long-term clinical and commercial success.

 

Modern Lab Maintenance Strategies For Complex Equipment

Modern lab equipment is essential to scientific research, but maintaining it is increasingly complex. Discover key challenges and strategies to futureproof your maintenance approach.

 

Next Generation Sequencing In Viral Safety Testing

Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.

 

The Alternative Solution To Comply With The New GMP Annex 1

Rising Annex 1 demands are pushing facilities to rethink contamination control. See how RABS retrofits offer a practical path to compliance, combining effective containment and faster implementation.

 

Extractables And Leachables: A Critical Part Of CCS Under EU GMP Annex 1

Managing chemical migration from packaging and process equipment is essential to protect patient safety, maintain drug stability, and ensure regulatory compliance.

 

Integrating Enterprise IT And OT Data For Real-Time Insights

Paper-heavy production can slow decisions and limit flexibility. Read how IT/OT integration connects shop-floor and enterprise data to support real-time visibility and more resilient operations.

 

Fostering A Culture Of Clean Beyond The CCS Blueprint

Achieving sterile excellence requires more than just rigid protocols. Learn how to foster a proactive mindset across your entire organization to ensure long-term facility integrity.

 

Modular Cleanroom Infrastructure For High-Potency Therapy Containment

High-potency therapies demand stringent containment and worker safety. Delve into how scalable, modular infrastructure simplifies compliance and protects product integrity in regulated facilities.

 

Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

 

Simultaneous Submissions And Managing Multiple Regulatory Pathways

Regulators are increasingly aligned across markets. Follow how sponsors pursue simultaneous global submissions to streamline approval pathways.

 

The Switch To Cell-Free DNA: Strategic And Regulatory Considerations

Uncover how risk-based studies, quality attributes, and proactive regulatory engagement support confident transitions to cell-free DNA manufacturing.

SPONSOR

 

Strategies, Tools, And Techniques Shaping Viral Vector Production | 09.29.26

This session examines the latest strategies, tools, and technologies shaping viral vector development and manufacturing for gene therapies. Attendees will learn how advances in vector design, process development, and production are improving safety, potency, scalability, and regulatory readiness. The discussion will also cover common manufacturing challenges and provide guidance for selecting experienced CDMO partners to support efficient, reliable viral vector production. Learn more.

REGULATORY & COMPLIANCE SOLUTIONS

Restore Control When It Matters Most - Ecolab Life Sciences

Accelerating Workflows Without Adding Manual Handoffs - Revvity Signals Software, Inc.

Build Consistency Into Your Lab With Automated Electrophoresis - Agilent Technologies

Quality Excellence Precision Driven By Closed-Loop Digital Tracking - MasterControl, Inc.

Cell Culture Isolator System For Ergonomic, Sterile, Scalable Processing - TEMA SINERGIE

Connect With Cell & Gene: